Terry Smith's ADMA Position Overview
Terry Smith (via Fundsmith Llp) currently holds 2.1 M shares of ADMA Biologics, Inc. (ADMA) worth $38.34 M, representing 0.22% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Terry Smith has initiated a new position in ADMA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Terry Smith's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Terry Smith
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2.1 M | New Buy | 2.1 M | $18.24 |
Terry Smith's ADMA Biologics Investment FAQs
Terry Smith first purchased ADMA Biologics, Inc. (ADMA) in Q4 2025, acquiring 2,102,054 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Terry Smith has held ADMA Biologics, Inc. (ADMA) for 1 quarters since Q4 2025.
Terry Smith's largest addition to ADMA Biologics, Inc. (ADMA) was in Q4 2025, adding 2,102,054 shares worth $38.34 M.
According to the latest 13F filing for Q4 2025, Terry Smith's firm, Fundsmith Llp, owns 2,102,054 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $38.34 M.
As of the Q4 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.22% of Terry Smith's publicly disclosed stock portfolio, making it one of their key holdings.
Terry Smith's peak holding in ADMA Biologics, Inc. (ADMA) was 2,102,054 shares, as reported at the end of Q4 2025.